The maker of Ozempic, Novo Nordisk, manufactures a GLP-1 drug called Wegovy that has the same active ingredient as Ozempic, semaglutide
October 29, 2025: Report Says 12% of Americans Have Used Ozempic or Another GLP-1 Drug About 12% of Americans have used Ozempic or another GLP-1 drug, many of whom have experienced severe side effects
The most likelycause is insufficient strength training
At Lipedema Surgical Solutions, we are committed to delivering compassionate, individualized care that empowers our patients to take back control of their health
Y.ZhouQ
Overall, while the limited available evidence has shown mixed benefits of exercise snacking approaches for improving measures of metabolic and musculoskeletal health, the positive findings regarding the feasibility and acceptability of these approaches highlight the need for further work to determine and improve their efficacy in older adults, particularly those with sarcopenia and/or T2DM [181-184]